Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
△COMPANIESCompanies rated · 435 (no change)△PROJECTSProjects rated · 70 (no change)△CATALOGUE874 grants in catalogue · 19 open right now•POWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA△COMPANIESCompanies rated · 435 (no change)△PROJECTSProjects rated · 70 (no change)△CATALOGUE874 grants in catalogue · 19 open right now•POWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← Back to Eternal Search
François R. Martelet

François R. Martelet

individual
Fund operatorEcosystem influencer

About

François R. Martelet is a physician-executive in biopharma and oncology with more than 30 years in pharmaceutical and biotech leadership. He has served as CEO of Scandion Oncology and previously led NetScientific, while also chairing/leading multiple oncology and specialty-pharma businesses including Glycotest, Vivesto, TopoTarget, and AVAX Technologies. He currently appears publicly as a business advisor to Cleara Biotech and a board member of Novigenix.

Areas of interest

oncologybiotechdiagnosticsdrug developmentbiotech commercializationinvestor relationsstrategic partnershipsaging